image

Supplemental Figure 2 from MMP-1 and Pro-MMP-10 as Potential Urinary Pharmacodynamic Biomarkers of FGFR3-Targeted Therapy in Patients with Bladder Cancer

Abstract

FGFR3 siRNA and R3Mab diminish MMP-1 and MMP-10 mRNA leves in UMUC-14 cells.</p

    Similar works

    Full text

    thumbnail-image